Investing Profile

Rajeev Dadoo

VC
Managing Partner at SR One Capital Management
Photo of Rajeev Dadoo, Managing Partner at SR One Capital Management

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
1260 CONNECTIONS
Stanford University Network
1260 CONNECTIONS
SR One Capital Management Network
16 CONNECTIONS
cb
SR One Capital Management Managing Partner
9
CompanyStageDateRound SizeTotal Raised
Renalys Pharma
Series AJul 2024$39M
$39M
Nimbus Therapeutics
Private EquitySep 2023$210M
$640M
Co-investors: Bill Gates (Breakthrough Energy Ventures), Krishna Yeshwant (GV (Google Ventures)), Bruce Booth (Atlas Venture), Laura Stoppel (RA Capital Management), Peter Kolchinsky (RA Capital), Nikola Trbovic (Pfizer Venture Investments), Vicki Sato (ARCH Venture Partners)
Dren Bio
Series BJun 2022$65M
Series AOct 2020$60M
$130M
Co-investors: Sakae Asanuma (Hotmail), Andrew Schiff (Aisling Capital), Chandra Leo (HBM Partners AG)
ARS Pharmaceuticals
Series DAug 2021$55M
$55M
Co-investors: Peter Kolchinsky (RA Capital)
Tranquis Therapeutics
Series AJul 2020$30M
$30M
Co-investors: Taro Inaba (Remiges Ventures), Edgar Engleman (Stanford University)
iPierian
Series UnknownSep 2013$30M
Series BNov 2010$29M
$83M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Jim Scopa (Stanford University), Beth Seidenberg (Kleiner Perkins), Wesley Chan (FPV Fund), Martin Alexander Gershon (Endeavor Venture Funds)
IlluminOss Medical
Series CSep 2012$28M
$28M
Co-investors: Fouad Azzam (EQT Life Sciences)
Partner SR One2004 - Present
Managing Partner SR One Capital ManagementPresent
The Wharton School/Univ. Penn MBA Chemistry
Stanford University PhD Chemistry
Knox College BA
Stanford University PhD
The Wharton School/Univ. Penn MBA
Sign in with Google →
Sign in with Google →